Advertisement

Topics

Companies Related to "Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma" [Most Relevant Company Matches] [Advanced Search Results] RSS

19:19 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma" found in our extensive corporate database of over 50,000 company records.

Showing "Study Hydroxychloroquine Before Surgery Patients With Primary Renal" Companies 1–25 of 5,700+

Relevant

Advicenne

Advicenne (Euronext: ADVIC) is a pharmaceutical company developing pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases. The Company’s lead product is ADV7103 which has demonstrated positive results in a European pivotal phase 3 study in children and adults with distal Tubular Renal Acidosis (dTRA), is also being...


U.S. Renal Care, Inc.

Founded in 2000 by an experienced team of healthcare executives, U.S. Renal Care, Inc. works in partnership with nephrologists to develop, acquire, and operate outpatient treatment centers for persons suffering from chronic kidney failure, also known as End Stage Renal Disease. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis and p...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...


NxStage Medical

NxStage Medical is not your typical medical products company. We are a close-knit team of talented professionals driven by a shared commitment: to lead a movement to dramatically improve renal care with innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. We pursue this goal through a passionate commitment to Innovate, Educate and Advocate for the breakthrou...

NephroPath

Time to diagnosis can have a critical effect on the ultimate outcome of many renal diseases, and when a patient undergoes an invasive procedure such as a renal biopsy, there can be significant anxiety while the results are pending. Over the last 14 years, Dr. Patrick Walker, our Director and one of the nation's leading renal pathologists, has developed a unique system for rapid processing of renal...

SurgOne, P.C.

SurgOne surgeons are dedicated to providing the best possible care to our patients and their families. We have offices in the south metro Denver area, and our depth of expertise often brings patients from throughout the Rocky Mountain region. We have expertise and specially trained surgeons involved in Breast Surgery, Colorectal Surgery, Laparoscopic Surgery, Transplant Surgery, and Weight-Loss Su...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Diaverum

Diaverum ™ is a world leading provider of renal health care. The company has operations in 14 countries and provides treatment to around 16.000 patients. Diaverum differs from other providers through personalized in renal health care. For more information please visit our corporate website www.diaverum.com

ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

Frenova Renal Research

Frenova is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research. As a Fresenius Medical Care North America company, Frenova manages a networked system of clinical research assets and resources including over 450 principal investigators at more than 260 sites representing 160 m...

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

Renal Ventures Management, LLC

Renal Ventures Management, LLC is a leading provider of dialysis services. The company partners with top physicians to provide patients with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its nephrologist partners, Renal Ventures Management provides management expertise and patient-focused care operations which ce...

About Renal Ventures Management, LLC

Renal Ventures Management LLC is a leading provider of dialysis services in the U.S. The company partners with hospitals and physicians to provide patients suffering from chronic kidney failure with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its hospital and nephrologist partners, Renal Ventures Management pro...

Cromwell Hospital

The Cromwell Hospital in London provides healthcare facilities for UK and overseas patients. Major specialities include cancer treatment, liver disease and transplant, neurosurgery, spinal surgery, heart surgery, gamma knife surgery (radiosurgery), paediatric care, craniofacial surgery and urology.

Renal Ventures Management LLC

Renal Ventures Management LLC is a leading provider of dialysis services in the U.S. The company partners with hospitals and physicians to provide patients suffering from chronic kidney failure with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its hospital and nephrologist partners, Renal Ventures Management pro...

Corthera Inc.

Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent with this natural role of the hormone, pharmaceutically manufactured relaxin has been shown to have these effects in multiple human studies of men and non-preg...

Valentis

Valentis is a biotechnology company that was engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market. On July 11, 2006 Valentis announced that no statistically significant difference was seen in the primary endpoint or any of the secondary endpoints in its Phase IIb clinical trial of VLTS 934 in PAD. The primary efficacy endpoint in t...

Boca Raton Community Hospital

Born out of community need in 1967, Boca Raton Community Hospital is an advanced tertiary medical center (www.brch.com) with 400 beds and more than 700 primary and specialty physicians on staff. The hospital is a recognized leader in oncology, cardiovascular disease and surgery, minimally invasive surgery, orthopedics, women's health and emergency medicine, all of which offer state-of-the-art diag...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

Hurwitz Center for Plastic Surgery

Since 1977, Dr. Dennis Hurwitz, headquartered in Pittsburgh, Pennsylvania, has devoted his life to plastic surgery and body contouring. For decades, patients from around the country have turned to Dr. Hurwitz to help them refine and rejuvenate their appearance through cosmetic surgery. Now, Dr. Hurwitz is opening plastic surgery centers nationwide so that even more people can benefit from his uniq...

Northwest Weight Loss Surgery

Northwest Weight Loss Surgery,We understand that once you choose to have weight loss surgery, you want the best possible Lap Band surgeon.We are honored to have been selected by more patients than just about any other practice in the country.We do Lap Band surgery,We have been surgeons for a long time – but because we believe so strongly that weight loss surgery can have a tremendous impact...

Westlake Dermatology & Cosmetic Surgery

Westlake Dermatology & Cosmetic Surgery provides the very latest in skin rejuvenation and cosmetic and plastic surgery as well as state-of-the-art treatment for diseases of the skin. The practice of dermatology continues to be one of the fastest growing medical specialties with ongoing breakthroughs in skin care and repair. In our continuing commitment to ...

Catalyst OrthoScience Inc.

Catalyst OrthoScience develops and markets surgical implants that make orthopedic surgery less invasive and more efficient for both surgeons and patients. Catalyst was founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., who saw the need to make shoulder replacement surgery less invasive and give patients a more natural-feeling shoulder after su...


More From BioPortfolio on "Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks